<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36137496</PMID><DateCompleted><Year>2022</Year><Month>12</Month><Day>16</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2213-1582</ISSN><JournalIssue CitedMedium="Internet"><Volume>36</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>NeuroImage. Clinical</Title><ISOAbbreviation>Neuroimage Clin</ISOAbbreviation></Journal><ArticleTitle>Selective atrophy of the cervical enlargement in whole spinal cord MRI of amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>103199</StartPage><MedlinePgn>103199</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">103199</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.nicl.2022.103199</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2213-1582(22)00264-9</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a deadly neurodegenerative disorder affecting motor neurons in the spinal cord and brain. Studies have reported on atrophy within segments of the cervical cord, but we are not aware of previous investigations of the whole spinal cord. Herein we present our findings from a 3T MRI study involving 32 subjects (15 ALS participants and 17 healthy controls) characterizing cross-sectional area along the entire cord. We report atrophy of the cervical enlargement in ALS participants, but no evidence of atrophy of the thoracolumbar enlargement. These results suggest that MR-based analyses of the cervical cord may be sufficient for in vivo investigations of spinal cord atrophy in ALS, and that atrophy of the cervical enlargement (C4-C7) is a potential imaging marker for quantifying lower motor neuron degradation.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 The Author(s). Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Barry</LastName><ForeName>Robert L</ForeName><Initials>RL</Initials><AffiliationInfo><Affiliation>Athinoula A.Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Charlestown, MA, USA; Department of Radiology, Harvard Medical School, Boston, MA, USA; Harvard-Massachusetts Institute of Technology Health Sciences &amp; Technology, Cambridge, MA, USA. Electronic address: Robert.Barry@mgh.Harvard.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Torrado-Carvajal</LastName><ForeName>Angel</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Athinoula A.Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Charlestown, MA, USA; Medical Image Analysis and Biometry Laboratory, Universidad Rey Juan Carlos, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kirsch</LastName><ForeName>John E</ForeName><Initials>JE</Initials><AffiliationInfo><Affiliation>Athinoula A.Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Charlestown, MA, USA; Department of Radiology, Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arabasz</LastName><ForeName>Grae E</ForeName><Initials>GE</Initials><AffiliationInfo><Affiliation>Athinoula A.Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Charlestown, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Albrecht</LastName><ForeName>Daniel S</ForeName><Initials>DS</Initials><AffiliationInfo><Affiliation>Athinoula A.Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Charlestown, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alshelh</LastName><ForeName>Zeynab</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Athinoula A.Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Charlestown, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pijanowski</LastName><ForeName>Olivia</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Sean M.Healey &amp; AMG Center for ALS at Massachusetts General Hospital, Department of Neurology, Neurological Clinical Research Institute, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lewis</LastName><ForeName>Austin J</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>Sean M.Healey &amp; AMG Center for ALS at Massachusetts General Hospital, Department of Neurology, Neurological Clinical Research Institute, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Keegan</LastName><ForeName>Mackenzie</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Sean M.Healey &amp; AMG Center for ALS at Massachusetts General Hospital, Department of Neurology, Neurological Clinical Research Institute, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reynolds</LastName><ForeName>Beverly</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Sean M.Healey &amp; AMG Center for ALS at Massachusetts General Hospital, Department of Neurology, Neurological Clinical Research Institute, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Knight</LastName><ForeName>Paulina C</ForeName><Initials>PC</Initials><AffiliationInfo><Affiliation>Sean M.Healey &amp; AMG Center for ALS at Massachusetts General Hospital, Department of Neurology, Neurological Clinical Research Institute, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morrissey</LastName><ForeName>Erin J</ForeName><Initials>EJ</Initials><AffiliationInfo><Affiliation>Athinoula A.Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Charlestown, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Loggia</LastName><ForeName>Marco L</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>Athinoula A.Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Charlestown, MA, USA; Department of Radiology, Harvard Medical School, Boston, MA, USA; Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Atassi</LastName><ForeName>Nazem</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Sean M.Healey &amp; AMG Center for ALS at Massachusetts General Hospital, Department of Neurology, Neurological Clinical Research Institute, Boston, MA, USA; Department of Neurology, Harvard Medical School, Boston, MA, USA; Sanofi Genzyme, Cambridge, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hooker</LastName><ForeName>Jacob M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Athinoula A.Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Charlestown, MA, USA; Department of Radiology, Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Babu</LastName><ForeName>Suma</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Sean M.Healey &amp; AMG Center for ALS at Massachusetts General Hospital, Department of Neurology, Neurological Clinical Research Institute, Boston, MA, USA; Department of Neurology, Harvard Medical School, Boston, MA, USA. Electronic address: sbabu@mgh.Harvard.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 NS094306</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P41 EB030006</GrantID><Acronym>EB</Acronym><Agency>NIBIB NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 EB027779</GrantID><Acronym>EB</Acronym><Agency>NIBIB NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P41 EB015896</GrantID><Acronym>EB</Acronym><Agency>NIBIB NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS095937</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>09</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Neuroimage Clin</MedlineTA><NlmUniqueID>101597070</NlmUniqueID><ISSNLinking>2213-1582</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013116" MajorTopicYN="N">Spinal Cord</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001284" MajorTopicYN="N">Atrophy</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D066193" MajorTopicYN="Y">Cervical Cord</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Atrophy</Keyword><Keyword MajorTopicYN="N">Cervical enlargement</Keyword><Keyword MajorTopicYN="N">Cross-sectional area</Keyword><Keyword MajorTopicYN="N">Magnetic resonance imaging</Keyword><Keyword MajorTopicYN="N">Spinal cord</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest In the past two years, J.M.H. has consulted for Amathus Therapeutics, Rodin Therapeutics, Abata Therapeutics, FogPharma, Sanofi-Aventis, Longitude Capital, and the Alzheimer&#x2019;s Drug Discovery Foundation. J.M.H. is a paid Editor-in-Chief for ACS Chemical Neuroscience. J.M.H. is a co-founder and equity holder in Eikonizo Therapeutics (a license holder to J.M.H. patents) and in Sensorium Therapeutics. J.M.H. is a scientific advisory board member and equity holder in Psy Therapeutics, Delix Therapeutics, and Fuzionaire Diagnostics. J.M.H. has received sponsored research grants from Atai Life Sciences and Expesicor and has received honoraria for speaking or advisory service at non-profit academic institutions. N.A. is currently employed by Sanofi Genzyme. The other authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>3</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>8</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>9</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>9</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>9</Month><Day>22</Day><Hour>18</Hour><Minute>28</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36137496</ArticleId><ArticleId IdType="pmc">PMC9668597</ArticleId><ArticleId IdType="doi">10.1016/j.nicl.2022.103199</ArticleId><ArticleId IdType="pii">S2213-1582(22)00264-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Alshikho M.J., Z&#xfc;rcher N.R., Loggia M.L., Cernasov P., Chonde D.B., Izquierdo Garcia D., et al. Glial activation colocalizes with structural abnormalities in amyotrophic lateral sclerosis. Neurology. 2016;87:2554&#x2013;2561.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5207001</ArticleId><ArticleId IdType="pubmed">27837005</ArticleId></ArticleIdList></Reference><Reference><Citation>El Mendili M.M., Querin G., Bede P., Pradat P.F. Spinal cord imaging in amyotrophic lateral sclerosis: historical concepts &#x2013; novel techniques. Front Neurol. 2019;10:350.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6474186</ArticleId><ArticleId IdType="pubmed">31031688</ArticleId></ArticleIdList></Reference><Reference><Citation>Bede P., Bokde A.L.W., Byrne S., Elamin M., Fagan A.J., Hardiman O. Spinal cord markers in ALS: diagnostic and biomarker considerations. Amyotroph. Lateral Scler. 2012;13:407&#x2013;415.</Citation><ArticleIdList><ArticleId IdType="pubmed">22329869</ArticleId></ArticleIdList></Reference><Reference><Citation>Bede P., Querin G., Pradat P.F. The changing landscape of motor neuron disease imaging: the transition from descriptive studies to precision clinical tools. Curr. Opin. Neurol. 2018;31:431&#x2013;438.</Citation><ArticleIdList><ArticleId IdType="pubmed">29750730</ArticleId></ArticleIdList></Reference><Reference><Citation>Agosta F., Rocca M.A., Valsasina P., Sala S., Caputo D., Perini M., et al. A longitudinal diffusion tensor MRI study of the cervical cord and brain in amyotrophic lateral sclerosis patients. J. Neurol. Neurosurg. Psychiatry. 2009;80:53&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pubmed">18931009</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen-Adad J., El Mendili M.M., Morizot-Koutlidis R., Leh&#xe9;ricy S., Meininger V., Blancho S., et al. Involvement of spinal sensory pathway in ALS and specificity of cord atrophy to lower motor neuron degeneration. Amyotroph. Lateral Scler. Frontotemporal Degener. 2013;14:30&#x2013;38.</Citation><ArticleIdList><ArticleId IdType="pubmed">22881412</ArticleId></ArticleIdList></Reference><Reference><Citation>Querin G., El Mendili M.M., Lenglet T., Delphine S., Marchand-Pauvert V., Benali H., et al. Spinal cord multi-parametric magnetic resonance imaging for survival prediction in amyotrophic lateral sclerosis. Eur. J. Neurol. 2017;24:1040&#x2013;1046.</Citation><ArticleIdList><ArticleId IdType="pubmed">28586096</ArticleId></ArticleIdList></Reference><Reference><Citation>Paquin M.&#xca;., El Mendili M.M., Gros C., Dupont S.M., Cohen-Adad J., Pradat P.F. Spinal cord gray matter atrophy in amyotrophic lateral sclerosis. AJNR Am. J. Neuroradiol. 2018;39:184&#x2013;192.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7410702</ArticleId><ArticleId IdType="pubmed">29122760</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Burgh H.K., Westeneng H.J., Meier J.M., van Es M.A., Veldink J.H., Hendrikse J., et al. Cross-sectional and longitudinal assessment of the upper cervical spinal cord in motor neuron disease. Neuroimage Clin. 2019;24</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6734179</ArticleId><ArticleId IdType="pubmed">31499409</ArticleId></ArticleIdList></Reference><Reference><Citation>Delso G., F&#xfc;rst S., Jakoby B., Ladebeck R., Ganter C., Nekolla S.G., et al. Performance measurements of the Siemens mMR integrated whole-body PET/MR scanner. J. Nucl. Med. 2011;52:1914&#x2013;1922.</Citation><ArticleIdList><ArticleId IdType="pubmed">22080447</ArticleId></ArticleIdList></Reference><Reference><Citation>Chokshi F.H., Sadigh G., Carpenter W., Allen J.W. Diagnostic quality of 3D T2-SPACE compared with T2-FSE in the evaluation of cervical spine MRI anatomy. AJNR Am. J. Neuroradiol. 2017;38:846&#x2013;850.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7960240</ArticleId><ArticleId IdType="pubmed">28154126</ArticleId></ArticleIdList></Reference><Reference><Citation>De Leener B., L&#xe9;vy S., Dupont S.M., Fonov V.S., Stikov N., Collins D.L., et al. SCT: Spinal Cord Toolbox, an open-source software for processing spinal cord MRI data. Neuroimage. 2017;145:24&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pubmed">27720818</ArticleId></ArticleIdList></Reference><Reference><Citation>Gros C., De Leener B., Badji A., Maranzano J., Eden D., Dupont S.M., et al. Automatic segmentation of the spinal cord and intramedullary multiple sclerosis lesions with convolutional neural networks. Neuroimage. 2019;184:901&#x2013;915.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6759925</ArticleId><ArticleId IdType="pubmed">30300751</ArticleId></ArticleIdList></Reference><Reference><Citation>De Leener B., Fonov V.S., Collins D.L., Callot V., Stikov N., Cohen-Adad J. PAM50: unbiased multimodal template of the brainstem and spinal cord aligned with the ICBM152 space. Neuroimage. 2018;165:170&#x2013;179.</Citation><ArticleIdList><ArticleId IdType="pubmed">29061527</ArticleId></ArticleIdList></Reference><Reference><Citation>Grolez G., Kyheng M., Lopes R., Moreau C., Timmerman K., Auger F., et al. MRI of the cervical spinal cord predicts respiratory dysfunction in ALS. Sci. Rep. 2018;8:1828.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5789036</ArticleId><ArticleId IdType="pubmed">29379040</ArticleId></ArticleIdList></Reference><Reference><Citation>Wimmer T., Schreiber F., Hensiek N., Garz C., Kaufmann J., Machts J., et al. The upper cervical spinal cord in ALS assessed by cross-sectional and longitudinal 3T MRI. Sci. Rep. 2020;10:1783.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7000761</ArticleId><ArticleId IdType="pubmed">32020025</ArticleId></ArticleIdList></Reference><Reference><Citation>Ko H.Y., Park J.H., Shin Y.B., Baek S.Y. Gross quantitative measurements of spinal cord segments in human. Spinal Cord. 2004;42:35&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">14713942</ArticleId></ArticleIdList></Reference><Reference><Citation>Watson C., Paxinos G., Kayalioglu G. Academic Press; 2009. The spinal cord: a Christopher and Dana Reeve Foundation text and atlas.</Citation></Reference><Reference><Citation>Frostell, A., Hakim, R., Thelin, E.P., Mattsson, P., Svensson, M., 2016. A review of the segmental diameter of the healthy human spinal cord. Front Neurol. 7:238.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5179522</ArticleId><ArticleId IdType="pubmed">28066322</ArticleId></ArticleIdList></Reference><Reference><Citation>Babu S., Pioro E.P., Li J., Li Y. Optimizing muscle selection for electromyography in amyotrophic lateral sclerosis. Muscle Nerve. 2017;56:36&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pubmed">27759887</ArticleId></ArticleIdList></Reference><Reference><Citation>Shayya L., Babu S., Pioro E.P., Li J., Li Y. Distal predominance of electrodiagnostic abnormalities in early-stage amyotrophic lateral sclerosis. Muscle Nerve. 2018;58:389&#x2013;395.</Citation><ArticleIdList><ArticleId IdType="pubmed">29742797</ArticleId></ArticleIdList></Reference><Reference><Citation>Nijssen J., Comley L.H., Hedlund E. Motor neuron vulnerability and resistance in amyotrophic lateral sclerosis. Acta Neuropathol. 2017;133:863&#x2013;885.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5427160</ArticleId><ArticleId IdType="pubmed">28409282</ArticleId></ArticleIdList></Reference><Reference><Citation>Brettschneider J., Arai K., Del Tredici K., Toledo J.B., Robinson J.L., Lee E.B., et al. TDP-43 pathology and neuronal loss in amyotrophic lateral sclerosis spinal cord. Acta Neuropathol. 2014;128:423&#x2013;437.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4384652</ArticleId><ArticleId IdType="pubmed">24916269</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>